InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by JOHNSON DAVID LEE. Insider active across 1 companies, notably Global Blood Therapeutics, Inc.. Aggregated, 12 disclosures have been recorded. The latest transaction was filed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
4,375 shares
Common Stock
SEC:0000899243-22-013880:0·
€10,710472 shares@ €22.690235.1% of flow
Common Stock
SEC:0000899243-22-009262:0·
6,770 shares
Common Stock
SEC:0000899243-22-004634·
6,770 shares
Common Stock
SEC:0000899243-22-004634:0·
4,375 shares
Common Stock
SEC:0000899243-21-039183·
4,375 shares
Common Stock
SEC:0000899243-21-039183:0·
6,770 shares
Common Stock
SEC:0000899243-21-037667·
6,770 shares
Common Stock
SEC:0000899243-21-037667:0·
€9,913480 shares@ €20.6515100.0% of flow
Common Stock
SEC:0000899243-21-035223·
€9,913480 shares@ €20.651532.5% of flow
Common Stock
SEC:0000899243-21-035223:0·
6,770 shares
Common Stock
SEC:0000899243-21-031344·
6,770 shares
Common Stock
SEC:0000899243-21-031344:0·
12 of 12 declarations
About JOHNSON DAVID LEE
David Lee Johnson is a director at Global Blood Therapeutics, Inc.
